NSTE-ACS for Professionals

Find the latest resources on how to translate the NSTE-ACS Guidelines into practice

NSTE-ACS (non-ST elevation acute coronary syndrome) can be more challenging to diagnose than STEMI, and treatment options are based on symptoms and other risk factors, including readmission, morbidity and mortality risk. Treatment is divided into invasive (coronary intervention) or noninvasive (medical management) strategies according to the latest guidelines.


Sign up HERE


Sign up to receive additional information addressing NSTE-ACS, as well as related CME/CE activities.

NSTE-ACS CME/CE Webinar Series

This activity discusses the epidemiology, pathophysiology and clinical presentation of NSTE-ACS.

Register Now

This activity discusses early hospital care and identification of NTSE-ACS patients appropriate for medical and invasive therapy.

Register Now

This activity discusses late hospital care, effective hospital discharge and after NSTE-ACS and secondary prevention strategies for patients.

Register Now

Reviews clinical presentation, diagnosis and management of Non-ST Elevation Acute Coronary Syndromes (NSTE-ACS).

Register Now

GTO: A head start in the race to save livesGuideline Transformation & Optimization
This NSTE-ACS page for professionals is part of the Guidelines Transformation & Optimization Program and is supported by an educational grant from AstraZeneca. The American Heart Association’s Guideline Transformation & Optimization (GTO) Program is a comprehensive, coordinated approach to accelerate guidelines into clinical practice.

AstraZeneca is a proud inaugural sponsor of the American Heart Association’s Guideline Transformation and Optimization Initiative.

Learn More About the GTO Program
The redesigned 2018 Course Catalog: Learning designed with you in mind
CME/CE activities available 24/7 - Lifelong learning - visit us at learn.heart.org
Use our tools to empower your heart attack patients. New acute myocardial infarction toolkit for healthcare professionals - get the latest tools now.